Cardinal Health Inc. (NYSE:CAH) has a beta of 1.04, a 12-month trailing P/E ratio of 11.96, and a growth ratio of 1.58. The stock’s Relative Strength Index (RSI) is 64.82, with weekly volatility at 3.22% and ATR at 1.42. The CAH stock’s 52-week price range has touched low of $39.05 and a $59.46 high. Its shares traded higher over the last trading session, gaining 3.42% on 03/10/21. The shares fell to a low of $54.14 before closing at $56.17. Intraday shares traded counted 1.84 million, which was 4.25% higher than its 30-day average trading volume of 1.92M. CAH’s previous close was $54.31 while the outstanding shares total 294.00M.
Investors have identified the Medical Distribution company Cardinal Health Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $16.10 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cardinal Health Inc. (CAH) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CAH, the company has in raw cash 3.74 billion on their books with 13.0 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 30.11 billion total, with 25.75 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 6.19 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CAH sounds very interesting.
Is the stock of CAH attractive?
In related news, Chief Legal/Compliance Officer, Mayer Jessica L sold 3,500 shares of the company’s stock in a transaction that recorded on Feb 26. The sale was performed at an average price of 51.53, for a total value of 180,355. As the sale deal closes, the Chief Accounting Officer, English Patricia M now sold 3,291 shares of the company’s stock, valued at 171,066. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.30%.
5 out of 19 analysts covering the stock have rated it a Buy, while 12 have maintained a Hold recommendation on Cardinal Health Inc.. 0 analysts has assigned a Sell rating on the CAH stock. The 12-month mean consensus price target for the company’s shares has been set at $62.94.